AP2007003952A0 - Use of an anti-atherothrombotic compound inobtaining medicaments intended for the treatment of vascular disorders - Google Patents

Use of an anti-atherothrombotic compound inobtaining medicaments intended for the treatment of vascular disorders

Info

Publication number
AP2007003952A0
AP2007003952A0 AP2007003952A AP2007003952A AP2007003952A0 AP 2007003952 A0 AP2007003952 A0 AP 2007003952A0 AP 2007003952 A AP2007003952 A AP 2007003952A AP 2007003952 A AP2007003952 A AP 2007003952A AP 2007003952 A0 AP2007003952 A0 AP 2007003952A0
Authority
AP
ARIPO
Prior art keywords
inobtaining
atherothrombotic
compound
treatment
vascular disorders
Prior art date
Application number
AP2007003952A
Other languages
English (en)
Inventor
Laurence Lerond
Tony Verbeuren
Alain Rupin
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2007003952A0 publication Critical patent/AP2007003952A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2007003952A 2006-04-07 2007-03-26 Use of an anti-atherothrombotic compound inobtaining medicaments intended for the treatment of vascular disorders AP2007003952A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603082A FR2899473B1 (fr) 2006-04-07 2006-04-07 Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires

Publications (1)

Publication Number Publication Date
AP2007003952A0 true AP2007003952A0 (en) 2007-04-30

Family

ID=37084627

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007003952A AP2007003952A0 (en) 2006-04-07 2007-03-26 Use of an anti-atherothrombotic compound inobtaining medicaments intended for the treatment of vascular disorders

Country Status (40)

Country Link
US (1) US20070238785A1 (de)
EP (2) EP2105132A1 (de)
JP (1) JP2009532447A (de)
KR (2) KR20070100658A (de)
CN (2) CN101693025A (de)
AP (1) AP2007003952A0 (de)
AR (1) AR060288A1 (de)
AT (1) ATE452633T1 (de)
AU (1) AU2007201525A1 (de)
BR (1) BRPI0701597A (de)
CA (1) CA2582394A1 (de)
CO (1) CO5820217A1 (de)
CR (1) CR9020A (de)
CY (1) CY1109793T1 (de)
DE (1) DE602007003880D1 (de)
DK (1) DK1842537T3 (de)
EA (1) EA013874B1 (de)
ES (1) ES2338600T3 (de)
FR (1) FR2899473B1 (de)
GE (1) GEP20094782B (de)
GT (1) GT200700029A (de)
HR (1) HRP20100091T1 (de)
IL (1) IL182406A0 (de)
MA (1) MA28988B1 (de)
MX (1) MX2007004108A (de)
NI (1) NI200700083A (de)
NO (1) NO20071833L (de)
NZ (1) NZ554348A (de)
PE (1) PE20071147A1 (de)
PL (1) PL1842537T3 (de)
PT (1) PT1842537E (de)
RS (1) RS51207B (de)
SG (1) SG136882A1 (de)
SI (1) SI1842537T1 (de)
SV (1) SV2008003053A (de)
TN (1) TNSN07117A1 (de)
TW (1) TW200808306A (de)
UY (1) UY30263A1 (de)
WO (1) WO2007116138A1 (de)
ZA (1) ZA200702866B (de)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102862D0 (en) * 1991-02-11 1991-03-27 Erba Carlo Spa N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans
RU2120292C1 (ru) * 1992-07-22 1998-10-20 Российско-германское акционерное общество закрытого типа "УТИЛЕКС" Способ лечения мозговых сосудистых кризов
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE4343776A1 (de) * 1993-12-17 1995-06-22 Schering Ag Cyclopentanonderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
JPH08119936A (ja) * 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
FR2805261A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2857593B1 (fr) * 2003-07-18 2005-10-14 Servier Lab Composition pharmaceutique orodispersible d'un compose antithrombotique
FR2860436B1 (fr) * 2003-10-03 2006-01-20 Servier Lab Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire

Also Published As

Publication number Publication date
ZA200702866B (en) 2008-07-30
ES2338600T3 (es) 2010-05-10
DK1842537T3 (da) 2010-04-12
CO5820217A1 (es) 2007-11-30
JP2009532447A (ja) 2009-09-10
CN101693025A (zh) 2010-04-14
KR20070100658A (ko) 2007-10-11
RS51207B (sr) 2010-12-31
SG136882A1 (en) 2007-11-29
PL1842537T3 (pl) 2010-06-30
SI1842537T1 (sl) 2010-03-31
TW200808306A (en) 2008-02-16
EP1842537B1 (de) 2009-12-23
HRP20100091T1 (hr) 2010-04-30
AU2007201525A1 (en) 2007-10-25
US20070238785A1 (en) 2007-10-11
EA200700573A3 (ru) 2007-12-28
WO2007116138A1 (fr) 2007-10-18
AR060288A1 (es) 2008-06-04
CN101049292A (zh) 2007-10-10
EP1842537A1 (de) 2007-10-10
KR20090086500A (ko) 2009-08-13
PT1842537E (pt) 2010-01-15
MX2007004108A (es) 2009-02-16
DE602007003880D1 (de) 2010-02-04
ATE452633T1 (de) 2010-01-15
GEP20094782B (en) 2009-09-25
EA013874B1 (ru) 2010-08-30
BRPI0701597A (pt) 2007-12-11
GT200700029A (es) 2007-10-31
CY1109793T1 (el) 2014-09-10
NZ554348A (en) 2008-09-26
UY30263A1 (es) 2007-05-31
FR2899473B1 (fr) 2008-06-13
IL182406A0 (en) 2008-01-20
MA28988B1 (fr) 2007-11-01
NO20071833L (no) 2007-10-08
EA200700573A2 (ru) 2007-10-26
EP2105132A1 (de) 2009-09-30
NI200700083A (es) 2008-06-09
PE20071147A1 (es) 2007-12-22
TNSN07117A1 (fr) 2008-06-02
SV2008003053A (es) 2009-12-02
CR9020A (es) 2008-09-23
FR2899473A1 (fr) 2007-10-12
CA2582394A1 (fr) 2007-10-07

Similar Documents

Publication Publication Date Title
EP2166837A4 (de) Wirkstoffkombination zur behandlung von hauterkrankungen
EP1976377A4 (de) Verbindungen zur behandlung von stoffwechselstörungen
HK1126427A1 (zh) 用於治療與血管通透性相關的疾病的低劑量雷帕霉素
EP1983972A4 (de) Verbindungen zur behandlung von stoffwechselstörungen
ZA200805716B (en) Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
HK1131141A1 (en) Imidazolothiazole compounds for the treatment of disease
ZA200808963B (en) Compounds for the treatment of metabolic disorders
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
IL193747A0 (en) New therapeutic combinations for the treatment of depression
HK1166983A1 (zh) 包含用於治療疾病或紊亂的化合物的固體形式，其組合物，及其用途
IL196202A0 (en) Indazole derivatives for the treatment of hsp90-induced diseases
ZA200801667B (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
IL192852A0 (en) Compounds for the treatment of metabolic disorders
SI2234631T1 (sl) Spojine in postopki za zdravljenje ĺ˝ilne bolezni
IL193799A0 (en) New therapeutic combinations for the treatment or prevention of psycotic disorders
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
IL192851A0 (en) Compounds for the treatment of metabolic disorders
PL1982178T3 (pl) Sposoby leczenia zaburzeń afektywnych
IL195392A0 (en) Compounds for the treatment of metabolic disorders
GB0604782D0 (en) Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders
AP2007003952A0 (en) Use of an anti-atherothrombotic compound inobtaining medicaments intended for the treatment of vascular disorders
IL192982A0 (en) Compounds for the treatment of metabolic disorders
ZA200806180B (en) Benzoisoindole derivatives for the treatment of pain